Job description
In this role, you will contribute to cutting-edge computational methods that can help provide answers to millions of undiagnosed patients. Your work will focus on revolutionizing the classification of genetic variants and diseases using functional evidence and explainable AI, bridging the gap between advanced machine learning and clinical application.
Your tasks are:
- Exploring molecular dynamics and proteomics methods to enhance variant interpretation, which may also include a role for non-coding variation (e.g. promotors, enhancers, TFBSs, TADs, lncRNAs, etc)
- Developing AI models for classifying genetic variants based on functional impact that are explainable and clinically interpretable.
- Translating cutting-edge computational science into medical practice, in particular maximizing use of all phenotypic and molecular data collected.
- Collaborating with bioinformaticians, lab specialists and clinicians to integrate findings into real-world diagnostics.
Project AI-driven functional DNA interpretation for molecular diagnostics
Rare genetic diseases affect approximately 1 in 10 people, yet the majority never receive a molecular diagnosis. Without a diagnosis, patients are left without a prognosis, effective treatment options, or access to the right support groups. A molecular diagnosis hinges on classifying DNA variants as pathogenic (i.e. disease-causing) or benign and assignment to disease phenotypes. A significant portion of these variants—single base-pair changes known as missense variants—alter protein structures and functions. Despite decades of research and hundreds of predictive tools, about half of these missense variants are classified as Variants of Unknown Significance (VUS), meaning there is not enough evidence for a classification as either benign or pathogenic. As a result, much DNA variation with remains untapped, preventing life-changing diagnoses for countless individuals.
The field is currently undergoing a paradigm shift, moving beyond traditional prediction models based on indirect evidence (such as evolutionary conservation and allele frequencies) toward direct functional evidence, including protein stability and activity. This shift is driven by recent breakthroughs such as AlphaFold and AlphaMissense, opening new avenues for variant interpretation. In addition, better phenotypes can be extracted from health records using AI.
In this PhD project, you will work on developing computational methods that generate close approximations of functional evidence and meaningful predictions for variant classification, with a strong focus on explainability. This means not only building AI models but also carefully selecting and interpreting functional features to ensure clinical relevance. Once developed and validated, your methods will be implemented in a clinical setting, directly impacting patient care.